2023-07-01 2024-06-30 false Capium Accounts Production 1.1 08324325 2023-07-01 2024-06-30 08324325 bus:AbridgedAccounts 2023-07-01 2024-06-30 08324325 bus:FRS102 2023-07-01 2024-06-30 08324325 bus:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 08324325 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 08324325 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 08324325 2023-07-01 2024-06-30 08324325 2024-06-30 08324325 bus:RegisteredOffice 2023-07-01 2024-06-30 08324325 core:WithinOneYear 2024-06-30 08324325 core:AfterOneYear 2024-06-30 08324325 1 2023-07-01 2024-06-30 08324325 bus:Director1 2023-07-01 2024-06-30 08324325 bus:Director1 2024-06-30 08324325 bus:Director1 2022-07-01 2023-06-30 08324325 2022-07-01 08324325 bus:LeadAgentIfApplicable 2023-07-01 2024-06-30 08324325 2022-07-01 2023-06-30 08324325 2023-06-30 08324325 core:WithinOneYear 2023-06-30 08324325 core:AfterOneYear 2023-06-30 08324325 bus:EntityAccountantsOrAuditors 2022-07-01 2023-06-30 08324325 bus:OrdinaryShareClass1 2023-07-01 2024-06-30 08324325 bus:OrdinaryShareClass1 2024-06-30 08324325 bus:OrdinaryShareClass1 2022-07-01 2023-06-30 08324325 bus:OrdinaryShareClass1 2023-06-30 08324325 core:PlantMachinery 2023-07-01 2024-06-30 08324325 core:PlantMachinery 2024-06-30 08324325 core:PlantMachinery 2023-06-30 08324325 core:FurnitureFittings 2023-07-01 2024-06-30 08324325 core:FurnitureFittings 2024-06-30 08324325 core:FurnitureFittings 2023-06-30 08324325 core:ComputerEquipment 2023-07-01 2024-06-30 08324325 core:ComputerEquipment 2024-06-30 08324325 core:ComputerEquipment 2023-06-30 08324325 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-06-30 08324325 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-06-30 08324325 core:CostValuation core:Non-currentFinancialInstruments 2024-06-30 08324325 core:CostValuation core:Non-currentFinancialInstruments 2023-06-30 08324325 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-06-30 08324325 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-06-30 08324325 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-06-30 08324325 core:Non-currentFinancialInstruments 2024-06-30 08324325 core:Non-currentFinancialInstruments 2023-06-30 08324325 core:ShareCapital 2024-06-30 08324325 core:ShareCapital 2023-06-30 08324325 core:RetainedEarningsAccumulatedLosses 2024-06-30 08324325 core:RetainedEarningsAccumulatedLosses 2023-06-30 08324325 dpl:Item1 2023-07-01 08324325 dpl:Item1 2024-06-30 08324325 dpl:Item1 2022-07-01 08324325 dpl:Item1 2023-06-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 08324325
England and Wales

 

 

 

CLINICAL SERVICES LTD


Abridged Accounts
 


Period of accounts

Start date: 01 July 2023

End date: 30 June 2024
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 8,556    10,647 
8,556    10,647 
Current assets      
Debtors 32,186    49,855 
Cash at bank and in hand 116,495    61,758 
148,681    111,613 
Creditors: amount falling due within one year (108,863)   (80,499)
Net current assets 39,818    31,114 
 
Total assets less current liabilities 48,374    41,761 
Provisions for liabilities (2,139)   (2,023)
Net assets 46,235    39,738 
 

Capital and reserves
     
Called up share capital 4 100    100 
Profit and loss account 46,135    39,638 
Shareholders' funds 46,235    39,738 
 


For the year ended 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 17 March 2025 and were signed by:


-------------------------------
Mihir Kumar Jagabhai Vaghela
Director
1
General Information
CLINICAL SERVICES LTD is a private company, limited by shares, registered in England and Wales, registration number 08324325, registration address 2 Wood Close, Hatfield, AL10 8TY.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102(1A) The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:-

Plant and Machinery 20% Straight Line
Fixtures and Fittings 30% Reducing Balance
Computer Equipment 25% Reducing Balance
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees


Average number of employees during the year was 1 (2023 : 2).
3.

Tangible fixed assets

Cost or valuation Plant and Machinery   Fixtures and Fittings   Computer Equipment   Total
  £   £   £   £
At 01 July 2023 4,372    14,152    2,009    20,533 
Additions     1,408    1,408 
Disposals      
At 30 June 2024 4,372    14,152    3,417    21,941 
Depreciation
At 01 July 2023 4,372    4,446    1,068    9,886 
Charge for year   2,912    587    3,499 
On disposals      
At 30 June 2024 4,372    7,358    1,655    13,385 
Net book values
Closing balance as at 30 June 2024   6,794    1,762    8,556 
Opening balance as at 01 July 2023   9,706    941    10,647 


4.

Share Capital

Authorised
100 Class A shares of £1.00 each
Allotted, called up and fully paid
2024
£
  2023
£
100 Class A shares of £1.00 each 100    100 
100    100 

2